November has been an active month in the years-long litigation
of opioid manufacturers — and it hasn't been good for the
theories put forth by Attorneys General and local
governments. On November 1, Orange County Judge Peter Wilson,
in litigation brought by Orange, Santa Clara, and Los Angeles
Counties, along with the City of Oakland, ruled completely in favor
of the defendants, several opioid manufacturers. And then on
November 9, the Oklahoma Supreme Court overturned the $475 million
verdict against opioid manufacturer Johnson & Johnson.
Does this signal a weakening of state and local government
authority to pursue these actions? Not likely.
It's important to take a step back and look at the
underlying theories of these cases. While the thousands of
governmental actions have been brought to address a public health
crisis, at their core the actions against opioid manufacturers are
largely based on theories that are marketing/advertising
claims. In essence,